Health care stocks were edging down Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each easing 0.2%.
The iShares Biotechnology ETF (IBB) rose 0.2%.
In corporate news, Johnson & Johnson (JNJ) filed Tuesday a lawsuit seeking to stop the US Health Resources and Services Administration's attempts to block the company's rebate model under the federal 340B drug pricing program. Its shares added 0.2%.
Pulmatrix (PULM) shares surged more than 54% after the company said Wednesday it has reached a merger agreement with Cullgen.
Invizyne Technologies (IZTC) shares jumped 20% in recent trading in their Nasdaq debut.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。